Opinion

Alexandre Chan: The impact of oncology pharmacists using ePRO to manage symptoms in cancer patients

Photo taken from pharmacytimes.com

Jul 28, 2024, 07:30

Alexandre Chan: The impact of oncology pharmacists using ePRO to manage symptoms in cancer patients

Alexandre Chan, Founding Chair and Professor of Clinical Pharmacy, UCI School of Pharmacy and Pharmaceutical Sciences sharedon X:

“Read our article which shows the impact of oncology pharmacists using ePRO to manage symptoms in cancer patients. ePRO can also help mitigate health disparities. Thanks Hematology/Oncology Pharmacy Association (HOPA) for funding the study!”

Electronic Patient-Reported Outcome-Driven Symptom Management by Oncology Pharmacists in a Majority-Minority Population: An Implementation Study

Autors: Alexandre Chan, PharmD, Ding Quan Ng, Daniela Arcos, Matthew Heshmatipour, Benjamin J. Lee, Alison Chen, Lan Duong, Linda Van, Thomas Nguyen, Vuong Green, and Daniel Hoang,

The impact of

Source: Alexandre Chan/X

Alexandre Chan Alison Chen Benjamin J. Lee cancer Daniel Hoang Daniela Arcos Ding Quan Ng HOPA Lan Duong Linda Van Matthew Heshmatipour OncoDaily Oncology PharmD Thomas Nguyen Vuong Green

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage